Evidence map›Paper›PMID 40335705›Full record

ArticleNature2025

Author Correction: Matrix-producing neutrophils populate and shield the skin.

Tommaso Vicanolo, Alaz Özcan, Jackson LiangYao Li, Carla Huerta-López, Iván Ballesteros, Andrea Rubio-Ponce, Andra C Dumitru, Jose Ángel Nicolás-Ávila, Miguel Molina-Moreno, Pablo Reyes-Gutierrez and 28 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors.

Tommaso Vicanolo *Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Alaz Özcan *Vascular Biology and Therapeutics Program and Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Jackson LiangYao Li *Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0001-5197-193X
Carla Huerta-LópezCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-6943-3475
Iván BallesterosCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-6246-2353
Andrea Rubio-PonceCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Andra C DumitruCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0003-3574-0992
Jose Ángel Nicolás-ÁvilaCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-8301-7216
Miguel Molina-MorenoVascular Biology and Therapeutics Program and Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-3493-7470
Pablo Reyes-GutierrezVascular Biology and Therapeutics Program and Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Andrew D JohnstonDepartment of Dermatology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-5769-3106
Catherine MartoneDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-0633-1559
Eric GretoDepartment of Internal Medicine 3-Rheumatology and Immunology, Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
Antonio Quílez-AlvarezCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Enrique CalvoCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0001-9096-5233
Elena Bonzon-KulichenkoCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0003-0852-7520
Rebeca Álvarez-VelezCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-5286-4500
Ming Yao ChooiSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
Immanuel KwokSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
Blanca González-BermúdezCenter for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain.ORCID http://orcid.org/0000-0002-1266-0917
Benoit MalleretSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.ORCID http://orcid.org/0000-0001-9658-7528
Francisco M EspinosaInstituto de Ciencia de Materiales de Madrid, CSIC, Madrid, Spain.
Ming ZhangDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yu-Long WangDepartment of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID http://orcid.org/0000-0002-3830-7257
Dasheng SunOPO and Organ Transplantation Leading Group, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shu Zhen ChongSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
Ali El-ArmoucheInstitute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Kevin K KimDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Irina A UdalovaKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6716-2528
Valentina GrecoDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-6492-4603
Ricardo GarciaInstituto de Ciencia de Materiales de Madrid, CSIC, Madrid, Spain.ORCID http://orcid.org/0000-0002-7115-1928
Jesús VázquezCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0003-1461-5092
Ana DopazoCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-4910-1684
Gustavo R PlazaInstituto de Ciencia de Materiales de Madrid, CSIC, Madrid, Spain.ORCID http://orcid.org/0000-0002-5555-5498
Jorge Alegre-CebolladaCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Stefan UderhardtDepartment of Internal Medicine 3-Rheumatology and Immunology, Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany. Stefan.uderhardt@fau.de.ORCID http://orcid.org/0000-0002-2489-2109
Lai Guan NgShanghai Immune Therapy Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. nglaiguan@renji.com.ORCID http://orcid.org/0000-0003-1905-3586
Andrés HidalgoCentro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain. andres.hidalgo@yale.edu.ORCID http://orcid.org/0000-0001-5513-555X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.